These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22922663)

  • 1. Incidence of deepening of the upper eyelid sulcus after topical use of travoprost ophthalmic solution in Japanese.
    Maruyama K; Shirato S; Tsuchisaka A
    J Glaucoma; 2014 Mar; 23(3):160-3. PubMed ID: 22922663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of deepening of the upper eyelid sulcus after switching from latanoprost to bimatoprost.
    Aihara M; Shirato S; Sakata R
    Jpn J Ophthalmol; 2011 Nov; 55(6):600-4. PubMed ID: 21953485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of deepening of the upper eyelid sulcus in prostaglandin-associated periorbitopathy with a latanoprost ophthalmic solution.
    Sakata R; Shirato S; Miyata K; Aihara M
    Eye (Lond); 2014 Dec; 28(12):1446-51. PubMed ID: 25233818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery from deepening of the upper eyelid sulcus after switching from bimatoprost to latanoprost.
    Sakata R; Shirato S; Miyata K; Aihara M
    Jpn J Ophthalmol; 2013 Mar; 57(2):179-84. PubMed ID: 23233196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deepening of the upper eyelid sulcus caused by 5 types of prostaglandin analogs.
    Inoue K; Shiokawa M; Wakakura M; Tomita G
    J Glaucoma; 2013; 22(8):626-31. PubMed ID: 22936280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of deepening of the upper eyelid sulcus on treatment with a tafluprost ophthalmic solution.
    Sakata R; Shirato S; Miyata K; Aihara M
    Jpn J Ophthalmol; 2014 Mar; 58(2):212-7. PubMed ID: 24390604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of deepening of upper eyelid sulcus after topical use of tafluprost ophthalmic solution in Japanese patients.
    Maruyama K; Tsuchisaka A; Sakamoto J; Shirato S; Goto H
    Clin Ophthalmol; 2013; 7():1441-6. PubMed ID: 23885167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deepening of eyelid superior sulcus during topical travoprost treatment.
    Yang HK; Park KH; Kim TW; Kim DM
    Jpn J Ophthalmol; 2009 Mar; 53(2):176-179. PubMed ID: 19333704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral deepening of upper lid sulcus from topical bimatoprost therapy.
    Yam JC; Yuen NS; Chan CW
    J Ocul Pharmacol Ther; 2009 Oct; 25(5):471-2. PubMed ID: 19857110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fixed Combination of Travoprost and Timolol Maleate Reduces Intraocular Pressure in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Prospective Multicenter Open-Label Study.
    Nakano T; Mizoue S; Fuse N; Iwase A; Matsumoto S; Yoshikawa K
    Adv Ther; 2015 Sep; 32(9):823-37. PubMed ID: 26424331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bimatoprost versus travoprost in an Egyptian population: a hospital-based prospective, randomized study.
    Macky TA
    J Ocul Pharmacol Ther; 2010 Dec; 26(6):605-10. PubMed ID: 21034177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A three-month, multicenter, double-masked study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to travoprost 0.004% ophthalmic solution and timolol 0.5% dosed concomitantly in subjects with open angle glaucoma or ocular hypertension.
    Hughes BA; Bacharach J; Craven ER; Kaback MB; Mallick S; Landry TA; Bergamini MV
    J Glaucoma; 2005 Oct; 14(5):392-9. PubMed ID: 16148589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of topical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertension.
    Goldberg I; Cunha-Vaz J; Jakobsen JE; Nordmann JP; Trost E; Sullivan EK;
    J Glaucoma; 2001 Oct; 10(5):414-22. PubMed ID: 11711841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%.
    Maul E; Carrasco FG; Costa VP; Casiraghi JF; Vargas E; Sarmina JS; Mayol R
    Clin Ther; 2007 Sep; 29(9):1915-23. PubMed ID: 18035191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular hypotensive efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension.
    Cantor LB; WuDunn D; Cortes A; Hoop J; Knotts S
    Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S12-8. PubMed ID: 15016557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Topouzis F; Melamed S; Danesh-Meyer H; Wells AP; Kozobolis V; Wieland H; Andrew R; Wells D
    Eur J Ophthalmol; 2007; 17(2):183-90. PubMed ID: 17415690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery of deepening of the upper eyelid sulcus after switching from prostaglandin FP receptor agonists to EP2 receptor agonist: a 3-month prospective analysis.
    Sakata R; Fujishiro T; Saito H; Nakamura N; Honjo M; Shirato S; Miyamoto E; Yamada Y; Aihara M
    Jpn J Ophthalmol; 2021 Sep; 65(5):591-597. PubMed ID: 34283308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of travoprost 0.004% ophthalmic solution, six weeks after its laminated packaging had been removed, in primary open-angle glaucoma: a randomized, controlled, investigator-blinded study.
    Reis R; dos Santos LC; Vila MP; Magacho L
    Clin Ther; 2004 Dec; 26(12):2121-7. PubMed ID: 15823775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: a 6-month, masked, multicenter trial.
    Fellman RL; Sullivan EK; Ratliff M; Silver LH; Whitson JT; Turner FD; Weiner AL; Davis AA;
    Ophthalmology; 2002 May; 109(5):998-1008. PubMed ID: 11986110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between travoprost and central corneal thickness in ocular hypertension and open-angle glaucoma.
    Harasymowycz PJ; Papamatheakis DG; Ennis M; Brady M; Gordon KD;
    Cornea; 2007 Jan; 26(1):34-41. PubMed ID: 17198011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.